Analyst Rating: Will Navidea Biopharmaceuticals Inc (NAVB) Stock Outperform the Market?

Retrieved on: 2021-02-02 17:03:45

Tags for this article:

Click the tags to see associated articles and topics

Analyst Rating: Will Navidea Biopharmaceuticals Inc (NAVB) Stock Outperform the Market?. View article details on hiswai:

Excerpt

On average, analysts give Navidea Biopharmaceuticals Inc a Strong Buy rating. The average price target is $7.5, which means analysts expect the stock ...

Article found on: www.investorsobserver.com

View Original Article